Frontiers in Molecular Biosciences (Sep 2021)

ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology

  • Yuexin Guo,
  • Boya Wang,
  • Han Gao,
  • Lei Gao,
  • Rongxuan Hua,
  • Jing-Dong Xu

DOI
https://doi.org/10.3389/fmolb.2021.708336
Journal volume & issue
Vol. 8

Abstract

Read online

The 2019-nCoV is a rapidly contagious pneumonia caused by the recently discovered coronavirus. Although generally the most noticeable symptoms are concentrated in the lungs, the disorders in the gastrointestinal tract are of great importance in the diagnosis of 2019-nCoV. The angiotensin-converting enzyme 2 (ACE2), an important regulator of many physiological functions, including blood pressure and nutrients absorption, is recently identified as a vital entry for 2019-nCoV to enter host cells. In this review, we summarize its functions both physiologically and pathologically. We also elaborate its conflicting roles from the clews of contemporary researches, which may provide significant indications for pharmacological investigations and clinical uses.

Keywords